Literature DB >> 2497015

Serological techniques for diagnosis of fungal infection.

L de Repentigny1.   

Abstract

This review summarizes recent developments in the serodiagnosis of candidiasis, aspergillosis, cryptococcosis, histoplasmosis, blastomycosis, coccidioidomycosis, mucormycosis and sporotrichosis. A number of studies have substantiated the presence of circulating antigens in invasive candidiasis, invasive aspergillosis, disseminated histoplasmosis and coccidioidomycosis, and immunoassays for antigen detection provide moderate sensitivity but high specificity for disease. Improved detection may result mainly from repeated serum or concentrated urine samplings rather than from the development of more sensitive immunoassays. Immunoblot analysis of the serological response is a useful tool for the identification of immunogenic fungal components that elicit a specific antibody response in invasive disease. This method, and others, have been successfully applied to the study of the immune response to several fungi, including Candida, Aspergillus and Rhizopus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497015     DOI: 10.1007/bf01963470

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  154 in total

1.  Enzyme linked immunosorbent assay (ELISA) for IgG and IgE antibodies to protein and polysaccharide antigens of Aspergillus fumigatus.

Authors:  R Sepulveda; J L Longbottom; J Pepys
Journal:  Clin Allergy       Date:  1979-07

2.  Serodiagnosis of histoplasmosis and blastomycosis.

Authors:  S F Davies; G A Sarosi
Journal:  Am Rev Respir Dis       Date:  1987-08

3.  Comparison of the enzyme immunoassay, immunodiffusion, and complement fixation tests in detecting antibody in human serum to the A antigen of Blastomyces dermatitidis.

Authors:  B S Klein; J N Kuritsky; W A Chappell; L Kaufman; J Green; S F Davies; J E Williams; G A Sarosi
Journal:  Am Rev Respir Dis       Date:  1986-01

4.  Rapid enzyme-linked immunosorbent assay (ELISA) for Aspergillus fumigatus antibodies.

Authors:  M D Richardson; J M Stubbins; D W Warnock
Journal:  J Clin Pathol       Date:  1982-10       Impact factor: 3.411

5.  Immunodiagnosis of histoplasmosis in a compromised host.

Authors:  G A Land; J H Foxworth; K E Smith
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

6.  IgG antibodies to purified Aspergillus fumigatus antigens determined by enzyme-linked immunosorbent assay.

Authors:  H Schønheyder; P Andersen
Journal:  Int Arch Allergy Appl Immunol       Date:  1984

7.  Binding of C-reactive protein to Aspergillus fumigatus fractions.

Authors:  T D Jensen; H Schønheyder; P Andersen; A Stenderup
Journal:  J Med Microbiol       Date:  1986-03       Impact factor: 2.472

8.  Evaluation of the Ramco latex agglutination test in the early diagnosis of systemic candidiasis.

Authors:  J P Burnie; J D Williams
Journal:  Eur J Clin Microbiol       Date:  1985-04       Impact factor: 3.267

9.  Detection of a Trichosporon beigelii antigen cross-reactive with Cryptococcus neoformans capsular polysaccharide in serum from a patient with disseminated Trichosporon infection.

Authors:  E J McManus; J M Jones
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

10.  Detection of antibodies against Aspergillus fumigatus: comparison between double immunodiffusion, ELISA and immunoblot analysis.

Authors:  J Brouwer
Journal:  Int Arch Allergy Appl Immunol       Date:  1988
View more
  22 in total

1.  Diagnosis of disseminated candidiasis in hospitalized patients using the Cand-Tec latex agglutination assay.

Authors:  M L Sanchez; M A Pfaller; I Cabezudo; M Bale; B Buschelman
Journal:  Mycopathologia       Date:  1992-06       Impact factor: 2.574

Review 2.  Diagnosing fungal infections in immunocompromised hosts.

Authors:  C M Tang; J Cohen
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

3.  Comparison between PCR and detection of antigen in sera for diagnosis of pulmonary aspergillosis.

Authors:  S Kawamura; S Maesaki; T Noda; Y Hirakata; K Tomono; T Tashiro; S Kohno
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

4.  Value of detection of antibodies to Candida albicans germ tube in the diagnosis of systemic candidosis.

Authors:  G Quindós; J Pontón; R Cisterna; D W Mackenzie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

Review 5.  Aspergillus endocarditis and myocarditis in a patient with the acquired immunodeficiency syndrome (AIDS). A review of the literature.

Authors:  J N Cox; F di Dió; G P Pizzolato; R Lerch; N Pochon
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

6.  A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis.

Authors:  D Stynen; A Goris; J Sarfati; J P Latgé
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

7.  New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test.

Authors:  R Kappe; A Schulze-Berge
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

8.  Increased specificity of antibody detection in surgical patients with invasive candidiasis with cytoplasmic antigens depleted of mannan residues.

Authors:  A J van Deventer; H J van Vliet; L Voogd; W C Hop; W H Goessens
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

9.  Detection of antibodies to Candida albicans germ tube as a possible aid in diagnosing systemic candidiasis in bone marrow transplant patients.

Authors:  R Villalba; A I González; M J Linares; M Casal; A Torres
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267

10.  Improved immunodiagnosis of human candidiasis by an enzyme-linked immunosorbent assay using a Candida albicans 52-kilodalton metallopeptidase.

Authors:  B El Moudni; M H Rodier; G Daniault; J L Jacquemin
Journal:  Clin Diagn Lab Immunol       Date:  1998-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.